GR900300046T1 - Oxabicycloheptane derivatives, pharmaceutical composition and use - Google Patents
Oxabicycloheptane derivatives, pharmaceutical composition and useInfo
- Publication number
- GR900300046T1 GR900300046T1 GR90300046T GR900300046T GR900300046T1 GR 900300046 T1 GR900300046 T1 GR 900300046T1 GR 90300046 T GR90300046 T GR 90300046T GR 900300046 T GR900300046 T GR 900300046T GR 900300046 T1 GR900300046 T1 GR 900300046T1
- Authority
- GR
- Greece
- Prior art keywords
- group
- sup
- defined above
- pharmaceutically acceptable
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61042732A JPH0723367B2 (ja) | 1986-02-27 | 1986-02-27 | オキサビシクロヘプタン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR900300046T1 true GR900300046T1 (en) | 1991-07-31 |
Family
ID=12644212
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR90400555T GR3000693T3 (en) | 1986-02-27 | 1990-08-03 | Oxabicycloheptane derivatives, pharmaceutical composition and use |
GR90300046T GR900300046T1 (en) | 1986-02-27 | 1991-07-31 | Oxabicycloheptane derivatives, pharmaceutical composition and use |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR90400555T GR3000693T3 (en) | 1986-02-27 | 1990-08-03 | Oxabicycloheptane derivatives, pharmaceutical composition and use |
Country Status (8)
Country | Link |
---|---|
US (1) | US4713453A (el) |
EP (1) | EP0238883B1 (el) |
JP (1) | JPH0723367B2 (el) |
AT (1) | ATE52506T1 (el) |
CA (1) | CA1300138C (el) |
DE (1) | DE3762621D1 (el) |
ES (1) | ES2036183T3 (el) |
GR (2) | GR3000693T3 (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3054207B2 (ja) * | 1990-06-06 | 2000-06-19 | サントリー株式会社 | シクロプロパクロメン誘導体 |
JP3089040B2 (ja) * | 1990-06-06 | 2000-09-18 | サントリー株式会社 | 脳神経変性性疾患治療剤 |
US5401850A (en) * | 1990-06-06 | 1995-03-28 | Suntory Limited | Cyclopropachromen derivatives |
JP3993651B2 (ja) * | 1994-10-21 | 2007-10-17 | アスビオファーマ株式会社 | シクロプロパクロメンカルボン酸誘導体 |
BRPI0519784A2 (pt) * | 2004-12-28 | 2009-03-17 | Asubio Pharma Co Ltd | processo para a produção de compostos de aldose com carbono reduzido |
IT1400964B1 (it) * | 2010-06-15 | 2013-07-05 | Dipharma Francis Srl | Procedimento per la preparazione di derivati pteridinici |
WO2016134257A1 (en) | 2015-02-19 | 2016-08-25 | Lixter Biotechnology, Inc. | Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3468897A (en) * | 1966-10-05 | 1969-09-23 | Pierre Fournari | Certain 6-amino-2-(aryl or heteroaryl)-4-chromanone-hydrazones and derivatives |
JPS5829782A (ja) * | 1981-08-12 | 1983-02-22 | Nippon Zoki Pharmaceut Co Ltd | 新規複素環化合物、その製法及び該化合物を含有する医薬組成物 |
-
1986
- 1986-02-27 JP JP61042732A patent/JPH0723367B2/ja not_active Expired - Lifetime
-
1987
- 1987-02-27 US US07/019,973 patent/US4713453A/en not_active Expired - Fee Related
- 1987-02-27 ES ES198787102795T patent/ES2036183T3/es not_active Expired - Lifetime
- 1987-02-27 AT AT87102795T patent/ATE52506T1/de not_active IP Right Cessation
- 1987-02-27 CA CA000530795A patent/CA1300138C/en not_active Expired - Lifetime
- 1987-02-27 EP EP87102795A patent/EP0238883B1/en not_active Expired - Lifetime
- 1987-02-27 DE DE8787102795T patent/DE3762621D1/de not_active Expired - Lifetime
-
1990
- 1990-08-03 GR GR90400555T patent/GR3000693T3/el unknown
-
1991
- 1991-07-31 GR GR90300046T patent/GR900300046T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0238883B1 (en) | 1990-05-09 |
US4713453A (en) | 1987-12-15 |
CA1300138C (en) | 1992-05-05 |
JPH0723367B2 (ja) | 1995-03-15 |
ATE52506T1 (de) | 1990-05-15 |
EP0238883A1 (en) | 1987-09-30 |
ES2036183T3 (es) | 1993-05-16 |
DE3762621D1 (de) | 1990-06-13 |
JPS62198676A (ja) | 1987-09-02 |
GR3000693T3 (en) | 1991-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT81814B (pt) | Processo para a preparacao de derivados de naftaleno | |
IE801162L (en) | Pharmaceutical compositions | |
NO855204L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylcyklobutylalkylaminer. | |
KR890003691A (ko) | 피페리딘 유도체 및 그를 함유하는 부정맥을 위한 치료예방제 | |
ATE35137T1 (de) | Thieno(2,3-d)pyrimidin-derivate und deren salze. | |
EP0398720A3 (en) | Piperazine derivatives | |
GR900300046T1 (en) | Oxabicycloheptane derivatives, pharmaceutical composition and use | |
KR940003953A (ko) | 1. 4-벤조디옥산 유도체 | |
DE3363553D1 (en) | Substituted alpha-(ethyl)-alpha-(phenyl)-(omega-(dialkylamino)-alkoxy)-benzyl alcohols, their acid addition salts and quaternary salts, process for their preparation, as well as medicines containing these compounds | |
CA2118425A1 (en) | Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof | |
ES543802A0 (es) | Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo n-carbamiloxi sustituido | |
MY106235A (en) | New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them. | |
SE8603589D0 (sv) | Metylendioxifenantren- och stilbenderivat | |
ES8500054A1 (es) | Procedimiento para preparar derivados de sulfamoilbenzofenona. | |
ES8802425A1 (es) | Procedimiento para preparar derivados de esparteina. | |
GR860045B (en) | Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient | |
KR870006898A (ko) | 신장염 치료제 | |
KR910011258A (ko) | 녹내장의 치료방법 | |
HUT34943A (en) | Process for the production of new 1,1-diphenyl-propanol-derivatives, as well as of therapeutic preparations containing them | |
ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. |